Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Triple negative breast cancer encompasses several biological entities with different outcomes and is a priority to identify which patients require more treatment to reduce the risk of recurrence and which patients need less treatment. Patients and methods: Among the 210 women with first primary invasive apocrine non metastatic breast cancer operated on between January 1998 and December 2016 at the European Institute Oncology, Milan, we identified 24 patients with a pT1-pT2, node-negative, triple negative subtype and Ki-67 ≤ 20% who did not receive adjuvant chemotherapy (CT). We compared the outcome of this cohort with a similar group of 24 patients with ductal tumors who received adjuvant chemotherapy, matched by pathological stage and biological features and also with a similar group of 12 patients with apocrine tumors who received adjuvant chemotherapy. Results: The median age was 64 and 61 years in the apocrine (w/o CT) and ductal group, respectively. The median value of Ki-67 expression was 12% in the apocrine group (w/o CT) and 16% in the ductal group (p < 0.001). After a median follow-up of 7.5 years, no patients in the apocrine group (w/o CT) experienced a breast cancer related event compared with 4 events in the ductal carcinoma group (Gray test p-value = 0.11). Conclusions: The outcome of selected apocrine triple negative breast cancer patients who did not received adjuvant chemotherapy is excellent and supports a treatment de-escalation. Multicenter projects focusing on the possibility of avoiding adjuvant chemotherapy in selected subtypes of triple negative breast cancers with favorable outcome are warranted.

Original languageEnglish
Pages (from-to)138-142
Number of pages5
JournalBreast
Volume53
DOIs
Publication statusPublished - Oct 2020

Keywords

  • Adjuvant chemotherapy
  • Apocrine carcinoma
  • Special type

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy'. Together they form a unique fingerprint.

Cite this